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malaria
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Krupa B Playforth7, Karl B Seydel8, Steve Kamiza5, Malcolm E Molyneux9 and Terrie E Taylor8Abstract
Background: The sequestration of Plasmodium falciparum-infected erythrocytes in brain microvasculature through
cytoadherence to endothelium, is the hallmark of the definitive diagnosis of cerebral malaria and plays a critical role
in malaria pathogenesis. The complex pathophysiology, which leads each patient to the final outcome of cerebral
malaria, is multifaceted and thus, metrics to delineate specific patterns within cerebral malaria are needed to further
parse patients.
Methods: A method was developed for quantification utilizing counts of capillary contents (early-stage parasites,
late-stage parasites and fibrin) from histological preparations of brain tissue after death, and compared it to the
standard approach, in which the percentage of parasitized vessels in cross-section is determined.
Results: Within the initial cohort of 50 patients, two different observers agreed closely on the percentage of vessels
parasitized, pigmented parasites and pigment globules (ICC = 0.795-0.970). Correlations between observers for
correct diagnostic classification were high (Kendall’s tau-b = 0.8779, Kappa = 0.8413). When these methods were
applied prospectively to a second set of 50 autopsy samples, they revealed a heterogeneous distribution of
sequestered parasites in the brain with pigmented parasites and pigment globules present in the cerebellum >
cortex > brainstem. There was no difference in the distribution of early stages of parasites or in the percentage of
vessels parasitized across the same sites. The second cohort of cases was also used to test a previously published
classification and regression tree (CART) analysis; the quantitative data alone were able to accurately classify and
distinguish cerebral malaria from non-cerebral malaria. Classification errors occurred within a subclassification of
cerebral malaria (CM1 vs CM2). A repeat CART analysis for the second cohort generated slightly different
classification rules with more accurate subclassification, although misclassification still occurred.
Conclusions: The traditional measure of parasite sequestration in falciparum malaria, the percentage of vessels
parasitized, is the most reliable and consistent for the general diagnosis of cerebral malaria. Methods that involve
quantitative measures of different life cycle stages are useful for distinguishing patterns within the cerebral malaria
population; these subclassifications may be important for studies of disease pathogenesis and ancillary treatment.
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Five species of malaria parasite can infect humans, but
one, Plasmodium falciparum, is responsible for nearly
all of the severe morbidity and mortality in malaria-
endemic areas [1]. A distinguishing feature of P. falcip-
arum infections is the ability of infected erythrocytes,
especially those containing parasites in the latter half
of their life cycle, to adhere to the endothelium (i.e.
cytoadherence) of capillaries and post-capillary venules
[2]. This process leads to the accumulation of parasites
in tissues, a phenomenon known as sequestration, which
is so effective that mature, pigmented forms of P. fal-
ciparum are rarely seen in the peripheral blood [3-6].
Eventually, erythrocytes containing mature parasites
(schizonts) rupture, releasing merozoites and malaria
pigment, haemozoin. This malaria pigment is the
remnant of the parasite-driven process of haemoglo-
bin degradation and is scavenged and removed by
monocytes.
The clinical syndromes associated with P. falciparum
infections range from asymptomatic parasitaemia to
convulsions, coma and death. The mechanisms leading
to central nervous system dysfunction in severe malaria
have not been elucidated, but one hypothesis suggests
that sequestration of parasitized erythrocytes in cerebral
microvessels with resultant vascular congestion plays a
crucial part in pathogenesis [7,8]. To gain further insight
into this hypothesis, it is necessary to have a standar-
dized approach to assess cerebral tissue with respect to
malaria findings.
A clinicopathological study of fatal cerebral malaria is
ongoing in Blantyre, Malawi. A reproducible and bio-
logically relevant method of quantifying sequestration is
necessary before comparisons between sites within an
organ, or between patients, can be made. The traditional
method is to establish, in a given tissue sample, the pro-
portion of vessels which contain parasitized erythrocytes.
This figure is then used as the basis for comparisons
[9-13]. This approach was expanded this approach to in-
clude measures of the intensity of and life-cycle stage of
the sequestered parasites, using histological preparations
of brain tissue. The two approaches are described and
compared is this study. To evaluate the biological utility
of the measures, new cohort of patients was used to test
a classification system based on a previous CART ana-
lysis [14]. A new CART analysis using a second cohort
of patients was performed.
Methods
Patients
All patients were admitted to the Paediatric Research
Ward (Queen Elizabeth Central Hospital, Blantyre,
Malawi) between February 1996 and June 2010. Demo-
graphic, historical, clinical, and laboratory informationwere recorded for the duration of admission. The Blan-
tyre Coma Score [14] was used to estimate severity of
coma. Lumbar punctures to rule out meningitis were
performed on all children with altered consciousness
(Blantyre Coma Score <5) unless there was a clinical
contra-indication. Following diagnosis, children were
managed according to standard protocols as previously
described [15]. Clinical diagnoses were determined at
the time of discharge or death. Patients were assigned a
clinical diagnosis of cerebral malaria (Clin CM) if they
were admitted with coma (a Blantyre Coma Score ≤2
lasting for more than two hours after admission with no
evidence of meningitis), P. falciparum parasitaemia, and
no improvement following effective treatment for sei-
zures and hypoglycaemia. Comatose children who were
aparasitaemic on four consecutive blood smears col-
lected at six-hourly intervals were diagnosed as having
non-malarial comas (NM Coma). Parasitaemic children
without coma (Blantyre Coma Score >2 within two
hours of admission) and a haematocrit <15% were classi-
fied as having severe malarial anaemia (SMA). Parasitae-
mic children without coma (Blantyre Coma Score >2
within two hours of admission) were classified as having
other malarial illness (other). Parasitaemic children who
died before a clinical diagnosis could be determined
were grouped together as indeterminate. Parasitaemic
children with an obvious non-malarial cause of coma
were classified as non-malarial coma with incidental pa-
rasitaemia (NM Coma IP). All were treated initially
with quinine; blood and antibiotics were administered
according to standard criteria, and the treatment regi-
men was adjusted as the working diagnosis evolved [15].
The study was approved by the ethics committees at the
University of Liverpool, Michigan State University, and
the University of Malaŵi College Of Medicine.
Autopsies
In the event of a death, a Malaŵian clinician met with
key family members to discuss the possibility of per-
forming an autopsy. When permission was granted, au-
topsies were performed in the mortuary of the Queen
Elizabeth Central Hospital. The brain was cut directly at
autopsy and blocks from standard regions were fixed in
10% pH neutral buffered formalin, processed per routine
protocol, and embedded in paraffin. Sections cut at 5 μ
were stained with haematoxylin and eosin.
Pathological classification
Histological sections of brain tissue were reviewed by
pathologists (RAC, DM, SK and RW) who were blinded
to the clinical diagnosis and were classified as follows:
sequestration only (CM1); sequestration and extravascu-
lar pathology including ring haemorrhages (CM2); and
no evidence of sequestration/malarial pathology (CM3).
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matically to determine cause of death.
Quantitative method training
Fourteen cases with high rates of parasite sequestration
(>50% of capillaries parasitized) in the cerebral micro-
vasculature were included. Each was coded and an area
was outlined on each slide where the grey matter was
sectioned perpendicularly to the meningeal surface of
the brain. The slide was secured on a standard micro-
scope such that the outlined area of grey matter ran per-
pendicularly to the up/down or side/side direction of the
microscope stage. Consecutive fields were counted, per-
pendicular to the meningeal surface, running toward
the border between grey and white matter. At the
completion of a run, the slide was moved across two
field-widths followed by a second run back up to the
meningeal surface. Microscope fields were assessed sys-
tematically until at least 100 cross-sectioned capillariesFigure 1 Examples of capillary contents. Note that only the capillaries in
method; the other panels are illustrative of parasite elements but would no
original magnification.were identified and a run was complete (see Additional
file 1 for counting method tutorial). Capillaries (Figure 1)
were defined as a circular or oval blood vessel profile
with a maximum-to-minimum diameter of ≤2:1 and hav-
ing at most one visible endothelial cell nucleus in the
wall. Examples of the vessels encountered in a routine
section are shown in Figure 1 and include the following:
(A) A single unpigmented parasites in a vessel; (B) a
cluster of unpigmented parasites within a capillary; (C) a
cluster of unpigmented parasites in an elongated vessel;
(D) two pigmented parasites in a capillary; (E) several
pigmented parasites in a longitudinal vessel; (F) a large
clustered of pigmented parasites in a capillary; (G) three
pigmented parasites in a longitudinal vessel; (H) two
pigmented parasites in a capillary; (I) a white blood cell
containing many globules of pigment within a longitu-
dinal vessel; (J) a white blood cell containing many glo-
bules of pigment within a capillary; (K) a white blood
cell with pigment within a dilated capillary; (L) aPanels B, D, F, H, J, K, and L would be adequate for counting by our
t be used for counting. All images haematoxylin and eosin at 1,000×
Table 1 Intraclass correlation co-efficient
Variable Intraclass 95% CI
Correlation
Coefficient
% Vessels Parasitized (vpc) 0.970 0.948 0.983
Unpigmented Parasites (upp) 0.314 0.039 0.545
Pigmented Parasites (pp) 0.823 0.706 0.900
Pigment (pg) 0.905 0.837 0.945
Total Pigment (tpg) 0.928 0.876 0.959
Fibrin 0.284 0.006 0.522
Intraclass correlation co-efficient (CV) for two observers (NF and DM)
comparing counts for the first 50 cases by each element.
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haemorrhage. Individual elements were quantified as
follows:
– unpigmented parasites (UPP): Parasites were
counted as unpigmented if no pigment was seen
within the erythrocyte and if the parasite generally
occupied less than one third of the diameter of the
erythrocyte (Figure 1B and 1C);
– pigmented parasites (PP): The common feature in
these parasitized erythrocytes is the presence of
malarial pigment which can vary in size from a
small black dot to a less well defined larger mass of
brown/black pigment (Figure 1D-1H, 1J);
– extra-erythrocytic malaria pigment (PG): Malaria
pigment appears as a single mass of ill-defined
black pigment associated with a ‘ghost’ red blood
cell, free in the vessel, or as multiple masses within
intravascular white blood cells (Figure 1G, 1I-1K);
– the traditional measure (percentage of cross-
sectioned vessels containing intact parasites (%VP);
and fibrin: Identified on hematoxylin and eosin stain
and quantified per 100 capillaries (Figure 1L).
Counts were performed twice by an experienced ob-
server (RAC), and twice by three other individuals (CP,
DM, and NF), following instruction by, and under the
supervision of the experienced observer. All counts
were made without knowledge of the results of other
readings.
Quantitative method study
Slides from the first 50 autopsies (MP1 to 50) of the
series were prepared from the parietal lobe, midbrain,
and cerebellum and the various parasite elements were
counted as described above by a single observer (NF).
For the parietal lobe, a second observer (DM) counted
all parasite elements for all 50 cases. Modifications of
the method were required in the occipital grey matter
(data not utilized in this manuscript) where the runs
were completed to the meningeal surface of white mat-
ter/grey matter junction when a minimum of 100 vessels
had been assessed. In order to represent different layers
within each region of the brainstem equally, areas on the
para-sagittal plane of each slide were delineated, running
in the longest possible axis. Runs were completed from
the top to the bottom of the area to include a minimum
of 100 vessels. In the cerebellum, an area of the slide
was chosen in which the cerebellar folia were well repre-
sented, and consecutive fields were counted, running
within the molecular layer of the folia until 100 vessels
were examined. The results of this quantification (for
NF only) were previously analysed using CART and pub-
lished [15].Brain distribution study
For a subset of 28 of the first 50 cases, counts were
performed on the parietal lobe, occipital lobe, midbrain,
pons, medulla, and cerebellum by one observer (CP).
CART analysis (validation and repeat)
Slides from the second 50 cases of the series (MP51 to
100) were prepared from one area of the cortex (parietal
lobe). The various parasite elements were counted as des-
cribed by a single observer (DM). Counts were performed
blinded to the clinical and pathological diagnoses.
Statistics
Reliability in quantification of parasite elements
The complete counts for the first 50 cases (regardless of
clinical and pathological diagnosis) were compared bet-
ween two observers (NF and DM) for each element by
analysis of agreement (Bland-Altman plot), reproducibi-
lity (intraclass correlation co-efficients with 95% confi-
dence intervals), and correlation (visualization of scatter
plots and Spearman correlation co-efficients). Regression
analysis for each variable was also performed. Additio-
nally agreement for case classification as based on clin-
ical and histopathological diagnosis of each observer was
assessed via weighted Kappa co-efficients with corres-
ponding P-values. Classification of the 50 cases was
performed through %VP with cut-offs and rule defined
by the previous CART analysis. For each observer, the
cases were classified by the actual counts. Distribution
of each element between the two observers was com-
pared based on means and t-tests with p-values adjusted
for multiple testing via Bonferroni approach (0.05/70).
CART analysis (validation and repeat)
All counted parasite elements were normalized to 100
vessels for all patients and the following variables were
used as potential node differentiators:- UPP, PP, PG,
TPG, fibrin, and %VP. For the purposes of clinical vali-
dity, all patients who met the clinical case definition
of cerebral malaria were included as categories for
Table 2 Comparison of the clinicopathological diagnosis
with the histological count classification
Comparison Agreement**** Kappa* P-value
CM** vs. NF*** 97.55% 0.9532 <0.0001
CM vs. DM*** 97.96% 0.9612 <0.0001
NF vs. DM 96.33% 0.9302 <0.0001
*Weighted kappa based on [1, 0.8 1, 0 0 1] matrix.
**The CM classification is based on the clinical data (whether or not the
patient met the clinical case definition of cerebral malaria) plus the
pathological data in three categories (1 = sequestration only, 2 = sequestration
plus extravascular pathology, 3 = non-malaria cause of death). For the
purposes of this analysis, all malaria pathology negative patients (including
those that met the clinical case definition but died of another cause) are
categorized as 3. Two early cases who died very quickly without proper clinical
assessment are classified as 1 for this analysis based solely on pathology.
*** For both NF and DM, the counts produced for the cases were used to
classify the patients as 1 (if % of vessels parasitized >23.3 and total pigment
globules <55.5), 2 (vessels parasitized >23.3 and total pigment >55.5) or 3
(vessels parasitized <23.3) corresponding to the outcome of the classification
and regression tree analysis previously published [15].
**** Among the total 50 observations done by the two readers, proportion of
those in which both observers equally classified the case.
Comparison of the clinicopathological diagnosis (clinical data plus pathological
data final anatomic diagnosis) compared with the histological count
classification for both NF and DM.
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non-CM patients were excluded). Validation of the pre-
vious CART analysis was performed by classifying the
latter 50 cases with the rules established by the first 50
cases. Briefly, the rule identified by the previous CART
analysis classified as true CM (CM1 or CM2) patientsFigure 2 The distribution across 28 sequential cases of vessel seques
within the brain are shown as stacked bars (maximum= 600 represen
by mean % of vessels parasitized. The dotted horizontal line represents the
demonstrates that, for total brain quantification, there is a clear cut-off betw
malaria, cases 14–28).who had greater than 23% of vessels parasitized, CM2
patients as those with greater than 55.5 pigment globules
per 100 vessels, and as non-CM (CM3) patients as those
less than 25% of vessels parasitized. A repeat de novo
CART analysis was performed using only the latter 50
cases and this method was run with five times cross-
validation. CART software (Salford Systems, San Diego,
CA, USA) was used for all tree analysis.
Results
Patients
Data from 100 patients were included; 71 patients met
the clinical case definition of cerebral malaria of which
13 were pathologically classified as CM1, 39 as CM2,
and 19 as CM3. The remaining 29 patients included four
patients with SMA, 21 with non-malaria causes of coma
or other non-malarial illnesses, and four indeterminate
cases (the patients died before a clinical diagnosis could
be determined).
Reliability of quantification method
A Bland-Altman plot of %VP was performed first and
demonstrated excellent agreement between observers
(Additional file 2). The bias or difference in individual
counts between the two observers was generally 20 or
lower (within two standard deviations). The intraclass
correlation co-efficient (ICC) also showed very good totration (as measured by % of vessels parasitized) across six sites
ted 100% of vessels parasitized × 6 sites). Cases are ordered
overall cut off for “cerebral malaria” (23.3% × 6 sites = 139.8) and
een controls (non-cerebral malaria, cases 1–13) and cases (cerebral
Figure 3 The distribution across 50 sequential cases of vessel sequestration (as measured by % of vessels parasitized) across three
sites within the brain are shown as stacked bars (maximum= 300 represented 100% of vessels parasitized × 3 sites). Cases are ordered
by mean % of vessels parasitized. The dotted horizontal line represents the overall cut-off for “cerebral malaria” (23.3% × 3 sites = 69.9) and
demonstrates two outliers as follows: (grey arrow) a case of coma of other cause with anaemia and no evidence of retinopathy whose parietal
lobe measures was <23.3% but cerebellum was >23.3%; and (black arrow) a case of severe malaria anaemia whose parietal lobe measure was >23.3%
but the child did not meet the clinical case definition of cerebral malaria.
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dual elements (0.82-0.97), except for fibrin (0.284) and
UPP (0.314) (Table 1). Expert review of discrepant cases
showed that one observer systematically undercounted
UPP and overcounted fibrin. Visualization of the scatter
plots was consistent with reproducibility analysis, dem-
onstrating the strongest correlations between percentage
of vessels parasitized, total parasites per 100 capillaries,
and pigment measurements (Additional file 3). Classifi-
cation of cases based on the counts generated by either
observer using the CART rules was accurate with Kappa
scores >0.95 (Table 2). The mean of the individual para-
site elements, as counted by both observers across diag-
nostic categories, demonstrated significant differences
only in counts of fibrin and pigment globules (p < 0.0009
by Bonferroni) (Additional file 4).Figure 4 A graphical representation of the distribution of
diagnoses across parasite elements counted (early stage =
unpigmented rings, late stage = pigmented trophozoites,
pigment= total pigmentglobules) by medians demonstrating the
predominance of pigment in CM2 and the primary finding of late
stage parasites inmost infections for the validation set (n = 41).Brain distribution of parasite elements
Distribution was consistent throughout the brain such
that patients who were found to have high levels of
sequestration in one site consistently had sequestra-
tion across six sites for 28 selected cases (Figure 2 and
Additional file 5). Similarly, when counts in the first 50
cases were made across three sites, the distributions
were consistent and demonstrated that the cerebellum
was the site of highest sequestration for most cases
(Figure 3 and Additional file 6), although this difference
was not statistically significant. When individual parasite
elements (unpigmented early parasites vs pigmented late
parasites vs pigment only) were analysed across thepathological diagnoses, CM3 was significantly different
(p-values <0.001, Wilcoxon Rank Sum) from CM1 and
CM2 across all elements and CM2 had significantly
more pigment (p-value <0.01) than CM1 (Figure 4).CART analysis
Using the second cohort of 50 patients, %VP perfectly
distinguished subjects who had true CM from those with
non-CM diagnoses (CM1 or CM2 vs CM3). The levels
of %VP were very low for subjects with CM3 and indis-
tinguishable from control subjects. Using the previously
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Figure 5 A graphical representation of the first node of the
classification tree demonstrating that the resultant cut-offs
(23.3% and 21%) were stable but moot as the percentage of
vessels parasitized showed no overlap when only patients
meeting the clinical case definition of cerebral malaria
were analysed.
Figure 6 Study flow chart and classification results from CART analys
data from [15]. The validation study, using 40 new cases, is shown on the r
and a de novo set of classifications rules (based on the 40 new cases, lowe
sequestration from patients without evidence of cerebral sequestration) rem
node (separating patients with sequestration only from patients with seque
also remained stable (58.5 pg/100 vessels vs 55.5 pg/100 vessels). A third n
remainder of these latter two categories; however there were, in total, four
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and specificity of %VP to discriminate subjects among
patients meeting the clinical case definition (i.e., “true
CM” of CM1 or CM2 vs CM3) was 100% (Figure 5) [15].
Optimality of this cut-off level was confirmed by re-
analysing the second data set using CART; this showed
a nearly identical cut-off point (Figure 6). When trying
to further distinguish CM in patients with sequestration
only (CM1) and patients with sequestration and haemor-
rhages/extravascular pathology (CM2), the previously
defined rule (55.5 pg/100 vessels) did not perform well.
When categorizing subjects with sequestration only
(CM = 1) on the basis of %VP ≥23.3% and PG/100
V <55.5, among the eight subjects with sequestration
only, one was misclassified as sequestration and haemor-
rhage (12.5%). When categorizing subjects with seques-
tration and haemorrhages (CM = 2) on the basis of
%VP ≥23.3% and PG/100 V ≥55.5, among the 19 sub-
jects with sequestration and haemorrhages, eight were
misclassified as sequestration only (42.1%).
A next attempt included defining a new classification
rule to distinguish the three categories of clinical CM
using the testing dataset. As expert review revealed that
UPP and fibrin were under- and overcounted by one ob-
server, all elements for the new counts by the second
observer were used in the repeat CART analysis. Based
on the new rule, all patients with %VP ≤21.0%, a value
close to that emerging from the first CART analysis,
were classified as not having CM (13/13) (Figure 6).is. The initial training and testing study (on left) represents the original
ight with the original classifications rules applied (upper results table)
r results table). The first node (separating patients with any cerebral
ained stable (23.3% vs 21%) with no classification errors. The second
stration and extravascular pathology including ring haemorrhages)
ode was required (<= or >94.9 UPP/100 vessels) to separate the
classification errors using this new model.
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were correctly classified as patients with sequestration
only (8/8). Fifteen patients were correctly classified as
having sequestration with haemorrhages. However, four
patients who actually had sequestration with haemor-
rhages were misclassified as sequestration-only based on
the rulecombining %VP, PG and UPP.
Discussion
In a series of 50 autopsies performed on American sol-
diers dying of clinically defined cerebral malaria during
World War II, examination of haematoxylin and eosin-
stained slides showed that “the entire capillary network
of the brain…was distended with erythrocytes” in 46
cases [5]. The distribution of parasitized cells in the ca-
pillaries was noted to be “even and uniform”. Another
series, involving 50 Thai and Vietnamese patients dying
of severe malaria, used thin smears of brain tissue to
demonstrate a wide variation in the numbers of para-
sitized erythrocytes in the individual capillaries within
each brain [16]. In several of the brains from the Thai-
Vietnam series, some capillaries contained only unpa-
rasitized red cells, while others in the same sections had
100% of red cells parasitized. In both these studies, the
stages of development varied considerably from vessel to
vessel. This study attempts to develop a method that
could produce reliable and consistent counts of parasites
in brain capillaries, even if their distributions were not
uniform. In order to test the hypothesis that the seques-
tration of late-stage malaria parasites is responsible for
the mortality of cerebral malaria, it was important that
this method also distinguish parasites of different stages.
Stages were chosen that could be recognized on routine
histological sections. They were distinguished by the
presence or absence of malaria pigment and by its loca-
tion (intra- vs extra-erythrocytic). Young parasites have
no pigment and are the most difficult (along with fibrin)
to ascertain. Malaria pigment is unambiguously present
within infected erythrocytes after 30–34 hours of the 48-
hour P falciparum life cycle [17], and extra-erythrocytic
pigment reflects preceding rupture of mature schizonts.
The method involves assessing the proportion of cross-
sectioned capillaries containing parasitized erythrocytes
and quantifying the stages by counting UPP, PP and PG.
Of the four measures assessed, the traditional measure,
%VP, was most reliable. This measure includes both UPP
and PP, and discrepancies in their identification and
quantification would be absorbed in the more general
measure of %VP. This may have contributed to the en-
hanced reliability of %VP. The least reliable measures
were fibrin and UPP. Smaller studies of fibrin by special
stain have demonstrated that CM2 can have ~20% of
vessels containing fibrin while CM1 shows ~8% of cases
with fibrin (Samuel C Wassmer, pers comm). The currentvalidation data appears to have less fibrin than the training
data and suggests that studies of fibrin should always in-
clude a special stain for fibrin (rather than relying on the
appearance of fibrin as stained by haematoxylin and
eosin). Similarly, polarized light is a very useful tool for
quantifying pigment of any type. Upon expert review, it
was clear in the data that UPP were underestimated in the
training data by one observer and, thus, this element was
used in the repeat CART analysis (all counts by second
observer). For researchers employing this method, the use
of a superior light source in combination with extensive
training may be required for reliable measurement.
The method was used to compare the distribution of all
parasites elements in three different areas of the brain. Al-
though the cerebellum appears to be a site of slightly
higher overall sequestration, no statistically significant dif-
ferences in the distribution of parasite elements were ob-
served after correction for multiple testing.
Conclusions
A method was developed, validated and applied for de-
termining the intensity and distribution of malaria para-
sites by life-cycle stage in brain capillaries. Consistent
observations are possible, especially for the percentage
of vessels parasitized. These methods can be used on the
usual formalin-fixed, paraffin-embedded, haematoxylin
and eosin-stained tissue, and would allow for more stan-
dardized comparisons between different autopsy series.
This approach can be used for more detailed studies of
the intensity and stage distribution of malaria parasites
within and between Malaŵian children dying of falci-
parum malaria.
Additional files
Additional file 1: A demonstration of the counting methods used
are presented graphically as a slideshow with notes below each
slide explaining the method.
Additional file 2: A Bland-Altman difference plot for the % of
vessels parasitized (%VP) between two observers (NF and DM)
across the first 50 cases. The red line marks the mean and the blue
lines mark 1 standard deviation.
Additional file 3: The graphical correlations between NF and DAM
for all parasite elements are demonstrated and show that % of
vessels parasites, total parasites, and total pigment globules were
well correlate based on Spearman correlations, slope, and p-value.
Additional file 4: A comparison of the counts for each parasite
element made by NF and DAM across all diagnostic categories
(non-collapsed) is presented by element. Bonferroni and Sidak
corrections for the 70 comparisons sets the p-value at less than or equal
0.00074 for significance. For this level, the counts for fibrin (overall) and
pigment globules (overall and for CM2) were significantly different with
NF > DM for both measures.
Additional file 5: Additional examples of how different elements
are distributed across different diagnoses including total pigment,
total parasites, and fibrin based on counts by PC for six brain sites
across 28 patients. Data are shown as stacked totals across all sites. In
these figures, “non-CM” includes the single CM3 patient in the set of 28.
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http://www.malariajournal.com/content/12/1/191Additional file 6: The quantitative distribution of all parasite
elements across the first 50 case by overall measure and by each
diagnosis which demonstrates that, overall, fibrin appears to be
more common in the parietal lobe (p-value 0.0227); however, with
an appropriate p-value correction (by Bonferroni or Sidak), only
values of 0.0014 or less should truly be significant in this data set.
At the individual diagnosis level, there were no differences across sites
within an individual element.
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